133 related articles for article (PubMed ID: 19107071)
1. [Intra-annual and seasonal allergic conjunctivitis treatment: comparison of two therapeutic protocols].
Lazreg S; Colin J; Renault D; Hartani D
J Fr Ophtalmol; 2008 Dec; 31(10):961-7. PubMed ID: 19107071
[TBL] [Abstract][Full Text] [Related]
2. Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in vernal keratoconjunctivitis patients.
Leonardi A; Bremond-Gignac D; Bortolotti M; Violato D; Pouliquen P; Delval L; Grouin JM; Fregona IA
Br J Ophthalmol; 2007 Dec; 91(12):1662-6. PubMed ID: 17585003
[TBL] [Abstract][Full Text] [Related]
3. Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA.
Denis D; Bloch-Michel E; Verin P; Sebastiani A; Tazartes M; Helleboid L; Di Giovanni A; Lecorvec M
Br J Ophthalmol; 1998 Oct; 82(10):1135-8. PubMed ID: 9924299
[TBL] [Abstract][Full Text] [Related]
4. Comparison of topical 0.05% levocabastine and 0.1% lodoxamide in patients with allergic conjunctivitis. Study Group.
Richard C; Trinquand C; Bloch-Michel E
Eur J Ophthalmol; 1998; 8(4):207-16. PubMed ID: 9891891
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis.
Verin P; Easty DL; Secchi A; Ciprandi G; Partouche P; Nemeth-Wasmer G; Brancato R; Harrisberg CJ; Estivin-Ebrardt C; Coster DJ; Apel AJ; Coroneo MT; Knorr M; Carmichael TR; Kent-Smith BT; Abrantes P; Leonardi A; Cerqueti PM; Modorati G; Martinez M
Am J Ophthalmol; 2001 Jun; 131(6):691-8. PubMed ID: 11384563
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of N-acetyl aspartyl glutamic acid versus fluorometholone for treating allergic conjunctivitis in an environmental exposure chamber.
de Blay F; Gherasim A; Domis N; Choual I; Bourcier T
Clin Exp Allergy; 2022 Sep; 52(9):1091-1100. PubMed ID: 35302688
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of olopatadine therapy in seasonal allergic conjunctivitis].
Turlea M; Mârza F; Turlea C
Oftalmologia; 2009; 53(4):67-71. PubMed ID: 20361653
[TBL] [Abstract][Full Text] [Related]
8. [First Hungarian report of olopatadine eyedrop therapy in children and adults suffering from seasonal allergic conjunctivitis].
Endre L; Hidasi V
Orv Hetil; 2006 Sep; 147(36):1741-3. PubMed ID: 17087018
[TBL] [Abstract][Full Text] [Related]
9. [Seasonal and chronic allergic conjunctivitis in adults with children. Multicenter evaluation of the collyrium N-acetylaspartylglutamic acid (NAAGA) in ophthalmologic and allergy practices].
Bérard PV; Bérard PV; Mouillac-Gambarelli N; Jourdan-Fonta D
Bull Soc Ophtalmol Fr; 1987 Apr; 87(4):475-6, 479-83. PubMed ID: 3652358
[No Abstract] [Full Text] [Related]
10. [New drugs in the treatment of respiratory allergic diseases].
Gani F; Senna G; Crivellaro M; Dama A; Castellani L; Mezzelani P
Recenti Prog Med; 1997; 88(7-8):333-41. PubMed ID: 9324703
[TBL] [Abstract][Full Text] [Related]
11. N-acetyl-aspartyl glutamic acid (NAAGA) topical eyedrops in the treatment of giant papillary conjunctivitis (GPC).
Meijer F; Pogany K; Kok JH; Kijlstra A
Doc Ophthalmol; 1993; 85(1):5-11. PubMed ID: 7910133
[TBL] [Abstract][Full Text] [Related]
12. Topical azelastine in perennial allergic conjunctivitis.
Canonica GW; Ciprandi G; Petzold U; Kolb C; Ellers-Lenz B; Hermann R
Curr Med Res Opin; 2003; 19(4):321-9. PubMed ID: 12841925
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of lodoxamide 0.1% versus N-acetyl aspartyl glutamic acid 6% ophthalmic solutions in patients with vernal keratoconjunctivitis.
Gündüz K; Uçakhan O; Budak K; Eryilmaz T; Ozkan M
Ophthalmic Res; 1996; 28(2):80-7. PubMed ID: 8792357
[TBL] [Abstract][Full Text] [Related]
14. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.
Abelson MB; Torkildsen GL; Williams JI; Gow JA; Gomes PJ; McNamara TR;
Clin Ther; 2009 Sep; 31(9):1908-21. PubMed ID: 19843481
[TBL] [Abstract][Full Text] [Related]
15. Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis.
Williams JI; Kennedy KS; Gow JA; Torkildsen GL; Abelson MB; Gomes PJ; McNamara TR;
J Ocul Pharmacol Ther; 2011 Aug; 27(4):385-93. PubMed ID: 21649522
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of allergic conjunctivitis by thermography.
Hara Y; Shiraishi A; Yamaguchi M; Kawasaki S; Uno T; Ohashi Y
Ophthalmic Res; 2014; 51(3):161-6. PubMed ID: 24603108
[TBL] [Abstract][Full Text] [Related]
17. Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis.
Azevedo M; Castel-Branco MG; Oliveira JF; Ramos E; Delgado L; Almeida J
Clin Exp Allergy; 1991 Nov; 21(6):689-94. PubMed ID: 1685691
[TBL] [Abstract][Full Text] [Related]
18. Comparison of allergen immunotherapy and drug treatment in seasonal rhinoconjunctivitis: a 3-years study.
Giovannini M; Braccioni F; Sella G; Contoli M; Perri G; Frati F; Incorvaia C
Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):69-71. PubMed ID: 15859367
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, parallel-group comparison of olopatadine 0.1% ophthalmic solution versus placebo for controlling the signs and symptoms of seasonal allergic conjunctivitis and rhinoconjunctivitis.
Abelson MB; Turner D
Clin Ther; 2003 Mar; 25(3):931-47. PubMed ID: 12852709
[TBL] [Abstract][Full Text] [Related]
20. Onset of action, effectiveness and tolerance of levocabastine and nedocromil in topical therapy of seasonal allergic rhinoconjunctivitis. The Deutsche Rhinitis-Studiengruppe.
Kremer B; Tündermann A; Goldschmidt O
Arzneimittelforschung; 1998 Sep; 48(9):924-30. PubMed ID: 9793620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
